B. Metzler seel. Sohn & Co’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-36,171
| Closed | -$373K | – | 768 |
|
|
2023
Q4 | $373K | Buy |
36,171
+9,133
| +34% | +$94.3K | ﹤0.01% | 642 |
|
|
2023
Q3 | $213K | Sell |
27,038
-27,038
| -50% | -$213K | ﹤0.01% | 700 |
|
|
2023
Q2 | $540K | Buy |
54,076
+36,739
| +212% | +$367K | 0.01% | 576 |
|
|
2023
Q1 | $154K | Buy |
17,337
+4,526
| +35% | +$40.2K | ﹤0.01% | 720 |
|
|
2022
Q4 | $141K | Buy |
12,811
+2,418
| +23% | +$26.6K | ﹤0.01% | 713 |
|
|
2022
Q3 | $135K | Buy |
+10,393
| New | +$135K | ﹤0.01% | 723 |
|